IFNs can further lead to steatosis and NAFLD progression, possibly by modulating the expression of lipid metabolism-related genes, increasing de novo lipogenesis, increasing lipolysis in the peripheral tissues, insulin resistance, and increasing inflammation and cellular injury, apoptosis, or cell death, as depicted in Figure 3 and Figure 4. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.